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Identity 
Other names: P56-LCK LSK (T cell-specific protein-
tyrosine kinase); lck tyrosine kinase (AA 1-142); 
membrane associated protein tyrosine kinase 
proto-oncogene LCK; protein-tyrosine kinase 
put. ptk (135aa); tyrosine kinase 






DNA sequence is located on chromosome no.1 on the 
arm 1(p). 
Transcription 




















The kinase p56lck (509 aa) is a T-lymphocyte-specific 
member of the Src family of non-receptor protein 
tyrosine kinase. Lck is a 56 kDa phosphoprotein 
expressed in variety of lymphoid and non-lymphoid 
cell lineages. Lck contain myristylation sequence, 
unique amino-terminal regions, followed by Src 
homology domains SH3 and SH2, a tyrosine kinase 
catalytic domain, and C-terminal regulatory domain. 
Lck associates with the inner face of the plasma 
membrane through its amino-terminus. This interaction 
is mediated by both myristic acid and palmitic acid that 
are bound to the amino terminal glycine and Cys-3 
and/or Cys-5. The Unique region of Lck represents the 
domain possessing the greatest sequence diversity 
within this group of enzymes. This domain is thought 
to be involved in the interaction of the Lck with 
specific cellular proteins including Lck substrate. In T-
cells it is known, to mediate association with the 
cytoplasmic tail of T-cell coreceptors CD4 and CD8a. 
SH3 (Src homology 3) domain is mainly implicated in 
the regulation of protein-protein interactions, 
recognizing proline-rich region found in guanine 
nucleotide exchange factors and GTPase activating 
proteins. SH2 (Src homology 2) domain of Lck 
recognizes phosphorylated tyrosine residues on other 
proteins thereby facilitating the formation of tyrosine 
phosphorylation-induced multimeric complexes. The 
tyrosine kinase domain is the catalytic domain of Lck 
catalyzing the transfer of the gamma-phosphate from 
ATP to tyrosine residues on proteins. The catalytic 
domain contains a site of autophosphorylation (Tyr-
394), which plays an important role in regulating the 
protein kinase activity. A C-terminal regulatory domain 
is also seen containing the major site of tyrosine 
phosphorylation in vivo (Tyr-505). Phosphorylation of 
Csk (C-terminal Src kinase) at Tyr-505 leads to 
inactivation of Lck. Lck is also activated by oxidative 
stress. Reoxygenation after hypoxia induces Lck kinase 
activity. 
Expression 
Expressed in variety of lymphoid and non-lymphoid 









Shares sequence homology with other Src family 
kinases (Src, Hck, Fyn, Blk, Lyn, Fgr, Yes, and Yrk). 
Mutations 
Note 
Not reported yet. 
Implicated in 
Breast cancer, T-cell Leukemia, Colon 
carcinoma 
Oncogenesis 
Upregulation of Lck is seen in many cases of Breast 
cancer. It is also overexpressed in lymphoma, colon 
cancer. Rearrangement of LCK gene is also reported in 
murine lymphoma cell line. Oncogenic activation of 
Lck due translocation of the LCK gene is reported in 
the human HSB2 T-cell leukemia with t(1;7)(p34;q34) 
with LCK/ TCRB involvement. Lck regulates cell 
motility through NF-KB mediated uPA secretion 
following hypoxia and reoxygenation in Breast cancer. 
Disease 
Type 1 Diabetes. 
Prognosis 
T-cell mediated Type diabetes (Autoimmune disease) 
shows defect in TCR/CD3-mediated T-cell activation 
due to the abnormal expression of LCK. 
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